Skip to search formSkip to main contentSkip to account menu

Therapeutic brand of coal tar

Known as: therapeutics, Therapeutic, Therapeutic [brand name] 
brand name of topical coal tar
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Coal Tar

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Novel anticancer therapeutics targeting telomerase.
Review
2012
Review
2012
Nrf2: A Potential Target for New Therapeutics in Liver Disease
Nuclear erythroid 2–related factor 2 (Nrf2) is an oxidative stress–mediated transcription factor with a variety of downstream… 
Review
2007
Review
2007
Targeting the function of the HER2 oncogene in human cancer therapeutics
The year 2007 marks exactly two decades since human epidermal growth factor receptor-2 (HER2) was functionally implicated in the… 
Review
2007
Review
2007
ACE2: a new target for cardiovascular disease therapeutics.
The discovery of angiotensin-converting enzyme 2 (ACE2) in 2000 is an important event in the renin-angiotensin system (RAS) story… 
Review
2007
Review
2007
Targeting Checkpoint Kinase 1 in Cancer Therapeutics
Progression through the cell cycle is monitored by surveillance mechanisms known as cell cycle checkpoints. Our knowledge of the… 
Review
2006
Review
2006
Telomerase therapeutics for cancer: challenges and new directions
It has been approximately a decade since telomerase was described as an almost universal marker for human cancer. Most human… 
Review
2006
Review
2006
Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease.
Highly Cited
2005
Highly Cited
2005
Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
Review
2004
Review
2004
Glycomics: a pathway to a class of new and improved therapeutics
Complex glycans that are located at the surface of cells, deposited in the extracellular matrix and attached to soluble… 
Highly Cited
2002
Highly Cited
2002
The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
The ErbB1 and ErbB2 receptor tyrosine kinases (RTKs) play important roles in the development of numerous types of human cancer… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)